Experimental research on treating hepatic carcinoma by arterial injection of liposome mediated p53 genes

Journal of Interventional Radiology

Volumn 16, Issue 2, 2007, Pages 109-114

  Zhu, Guang Yu ^a   Lu, Qin ^a   Teng, Gao Jun ^a   Wei, Xiao Ying ^a   Guo, Jin He ^a   Yu, Hui ^a   Deng, Gang ^a   He, Shi Cheng ^a   Fang, Wen ^a   Li, Guo Zhao ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Hepatic carcinoma; Interventional; Liposome; p53 gene; Radiology; Transfection efficiency

Indexed keywords

IOHEXOL; LIPOFECTAMINE; LIPOSOME; MYC PROTEIN; PROTEIN; PROTEIN P53; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CATHETER; ARTICLE; CANCER MODEL; CANCER RESEARCH; CANCER TISSUE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOSE RESPONSE; GENE DOSAGE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; LIVER CARCINOMA; NONHUMAN; PLASMID; RABBIT; WESTERN BLOTTING;

EID: 33847768253     PISSN: 1008794X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Leong ASY. Epidemiology, risk factors, etiology, premalignant lesions and carcinogenesis [M]. //Leong ASY, Liew CT, Lau JWY, et al, Hepatocellular carcinoma: contemporary diagnosis, investigation and management. London: Arnold, 1999, 1-17.
2. Pauser S, Wanger S, Lippmann M, et al. Evaluation of efficient chemoembolization mixtures by magnetic resonance imaging therapy monitoring: An experimental study on the VX2 tumor in the rabbit liver[J]. Cancer Res, 1996, 56: 1863-1867
3. Chinese source.
4. Chinese source.
5. Habib NA, Hodgson HJ, Lemoine N, et al. A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours[J]. Hum Gene Ther, 1999, 10: 2019-2034.
6. Bookstein R, Demers W, Gregory R, et al. P53 gene therapy in vivo of hepatocellular and liver metastatic colorectal cancer [J]. Semin oncol, 1996, 23: 66-77.
7. Hirao K, Sugita T, Kubo T, et al. Targeted gene delivery to human osteosarcoma cells with magnetic cationic liposomes under a magnetic field[J]. Int J Oncol, 2003, 22: 1065-1071.
8. Gautam A, Waidrep JC, Densmore CL, et al. Growth inhibition of established B 16-F 10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin [J]. Gene Ther, 2002, 9: 353-357
9. Riva CM. Restoration of wild-type p53 activity enhances the sensitivity of pleural metastasis to cisplatin through an apoptotic mechanism[J]. Anticancer Res, 2000, 20: 4463-4471.
10. Pastorino F, Brignole C, Marimpietri D, et al. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications[J]. Ann N Y Acad Sci, 2004, 1028: 90-103.
11. Chipuk JE, Kuwana T, Bouchier-Hayes L, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis[J]. Science, 2004, 303: 1010-1014.
12. McPake CR, Shetty S, Kitchingman GR, et al. Wild-type p53 induction mediated by replication-deficient adenoviral vectors[J]. Cancer Res, 1999, 59: 4247-4251.
13. Bookstein R, Demers W, Gregory R, et al. p53 gene therapy in vivo of hepatocellular and liver metastatic colorectal cancer [J]. Semin Oncol, 1996, 23: 66-77.
14. Mohr L, Yoon SK, Eastman SJ, et al. Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice[J]. Hum Gene Ther, 2001, 12: 799-809.
15. Gharwan H, Wightman L, Kircheis R, et al. Nonviral gene transfer into fetal mouse livers (a comparison between the cationic polymer PEI and naked DNA) [J]. Gene Ther, 2003, 10: 810-817.
16. Ogris M, Wagner E. Tumor-targeted gene transfer with DNA polyplexes [J]. Somat Cell Mol Genet, 2002, 27: 85-95.